Table 2.

Supplemental immunization activities (SIAs) in response to cVDPV1 outbreak – Ukraine, 2015–2016.

Parameters	SIA dates	SIA type/vaccine used	Target age groups	No. targeted	No. vaccinated	Coverage reported,%	Coverage, post-campaign surveya, %
Coverage by SIA round as estimated by the Ministry of Health (MOH) and in a WHO-conducted post-campaign survey
SIA round 1	19 Oct-9 Nov 2015	Natl./tOPV	2 mos-5 yrs	2,298,922	1,480,936	64.4	69.0
SIA round 2	30 Nov-19 Dec 2015	Natl./tOPV	2 mos-5 yrs	2,291,374	1,643,142	71.7	68.9
SIA round 3	25 Jan-26 Feb 2016	Natl./tOPV	2 mos-9 yrs	3,704,676	2,990,436	80.7	67.9b
Coverage by cohort of targeted children by the end of SIA round 3
Age group	Per cent of children by number of vaccine doses received, as estimated by MOHc
	3 doses, %	2 doses, %	1 dose, %	0 doses, %	Total, %	≥1 dose, %	≥2 doses, %
2 mos-9 yrs	35.8	13.8	43.7	6.7	100	93.3	49.6
2 mos-5 yrs	59.5	22.3	13.6	4.6	100	95.4	81.8
2 yrs	62.0	20.8	13.5	3.7	100	96.3	82.8
3 yrs	62.4	21.0	12.6	4.0	100	96.0	83.4
4 yrs	63.3	20.6	12.2	3.9	100	96.1	83.9
5 yrs	63.7	20.2	12.5	3.6	100	96.4	83.9
1 yrs	58.5	24.2	14.2	3.1	100	96.9	82.7
2–11 mos	43.6	29.2	17.7	9.5	100	90.5	72.8
6–9 yrs	0.8	1.3	88.0	9.9	100	90.1	2.1

Abbreviations: Natl., national; N/A, not applicable; mos, months; yrs, years; tOPV, trivalent oral polio vaccine.

^aPost-campaign coverage survey implemented by WHO during February-March 2016.

^bReflects coverage among children 2 months-5 years targeted by the WHO post-campaign survey.

^cIncludes SIA tOPV doses as well as routine inactivated polio vaccine doses received during the SIA period.